InsiderOfficer

Ryan J. Watts Insider Trading Activity

Every SEC Form 4 transaction reported by Ryan J. Watts, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · Insider-trading data from SEC EDGAR
Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Ryan J. Watts buying or selling?

Ryan J. Watts reported 0 open-market buys ($0) and 51 sells ($41.2M) across 51 Form 4 filings at 1 company — a net selling position of $41.2M.

Source: SEC EDGAR Form 4

What stands out

  • All 51 of Ryan J. Watts's Form 4 filings are for one company, Denali Therapeutics Inc. (DNLI).
  • The most recent Form 4 was accepted on Jan 8, 2026 (9 months ago).
  • In the last 12 months: no open-market purchases and 1 sale ($580.8K).
  • The largest open-market sale in the last 12 months was $580.8K of Denali Therapeutics Inc. (DNLI) on Jan 8, 2026. SEC ↗

Key Statistics (as of Jan 8, 2026)

Total Form 4 filings
51
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (51)
$41.2M

Insider sentiment

Net selling

Net insider flow of $41.2M in net selling, filed between Aug 31, 2018 – Jan 8, 2026.

Companies Ryan J. Watts files for

#CompanyForm 4 filings
1DNLIDenali Therapeutics Inc.51

Recent Ryan J. Watts transactions

DateTickerRoleTypeSharesValueFiling
Jan 8, 2026DNLIPresident and CEOSale35.2K$580.8KSEC ↗
Jul 11, 2025DNLIPresident and CEOSale495.3K$7.4MSEC ↗
Jan 9, 2025DNLIPresident and CEOSale36.9K$751.0KSEC ↗
Oct 22, 2024DNLIPresident and CEOSale40.0K$1.1MSEC ↗
Aug 22, 2024DNLIPresident and CEOSale2.3K$53.8KSEC ↗
Feb 16, 2024DNLIPresident and CEOSale9.6K$165.8KSEC ↗
Jan 11, 2024DNLIPresident and CEOSale7.8K$154.6KSEC ↗
Jan 10, 2024DNLIPresident and CEOSale17.5K$339.7KSEC ↗
Aug 23, 2023DNLIPresident and CEOSale2.3K$52.2KSEC ↗
Aug 14, 2023DNLIPresident and CEOSale2.5K$63.2KSEC ↗
Jun 20, 2023DNLIPresident and CEOSale50.0K$1.6MSEC ↗
Apr 24, 2023DNLIPresident and CEOSale25.0K$628.7KSEC ↗
Feb 16, 2023DNLIPresident and CEOSale33.8K$1.0MSEC ↗
Feb 14, 2023DNLIPresident and CEOSale28.4K$832.5KSEC ↗
Jan 10, 2023DNLIPresident and CEOSale4.8K$136.5KSEC ↗
Jan 6, 2023DNLIPresident and CEOSale5.0K$144.5KSEC ↗
Aug 23, 2022DNLIPresident and CEOSale2.4K$79.9KSEC ↗
Feb 15, 2022DNLIPresident and CEOSale9.5K$329.5KSEC ↗
Feb 11, 2022DNLIPresident and CEOSale2.7K$102.1KSEC ↗
Jan 7, 2022DNLIPresident and CEOSale5.0K$224.2KSEC ↗
Dec 3, 2021DNLIPresident and CEOSale18.3K$823.6KSEC ↗
Nov 3, 2021DNLIPresident and CEOSale18.3K$912.2KSEC ↗
Oct 5, 2021DNLIPresident and CEOSale18.3K$923.6KSEC ↗
Sep 3, 2021DNLIPresident and CEOSale18.3K$1.0MSEC ↗
Aug 24, 2021DNLIPresident and CEOSale2.4K$117.8KSEC ↗

Showing the 25 most recent filings of 51. Screen every filing.

Ryan J. Watts insider trading FAQ

Is Ryan J. Watts buying or selling?

Across 51 SEC Form 4 filings, Ryan J. Watts reported 0 open-market purchases totaling $0 and 51 sales totaling $41.2M — a net selling position of $41.2M.

Which companies does Ryan J. Watts file Form 4s for?

Ryan J. Watts has reported insider transactions at 1 company, most often Denali Therapeutics Inc. (DNLI).

How far back does Ryan J. Watts's filing history go?

Trabud holds Ryan J. Watts's SEC Form 4 filings from Aug 31, 2018 – Jan 8, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Ryan J. Watts's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track Ryan J. Watts and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener